Medicine and Dentistry
Heparin
100%
Randomized Controlled Trial
100%
Unstable Angina Pectoris
100%
Glycoprotein IIb/IIIa Inhibitors
100%
Platelet Glycoprotein IIb/IIIa
100%
Low Drug Dose
45%
Drug Megadose
36%
Myocardial Infarction
18%
Platelet
18%
Acetylsalicylic Acid
18%
Q Wave
18%
Placebo
9%
Blood Clotting
9%
Bleeding
9%
Thrombocyte Activation
9%
Major Bleeding
9%
Infarction
9%
Heparinization
9%
Keyphrases
Heparin
100%
Randomized Controlled Trial
100%
Glycoprotein IIb/IIIa Inhibitors
100%
Stable Angina
100%
High Dose
50%
Ischemic Events
37%
Platelets
25%
Antagonism
25%
Placebo
12%
Infarction
12%
Thrombus Formation
12%
Aspirin Therapy
12%
Aspirin
12%
Platelet Activation
12%
Factorial Design
12%
Q Wave
12%
Major Bleeding
12%
Nonfatal Myocardial Infarction
12%
Heparin Therapy
12%
Plaque Rupture
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Fibrinogen Receptor
100%
Unstable Angina Pectoris
100%
Heparin Antagonist
100%
Heparin
72%
Acetylsalicylic Acid
18%
Heart Infarction
18%
Infarction
9%
Placebo
9%
Bleeding
9%
Thrombus
9%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Heparin
100%
Platelet Glycoprotein IIb/IIIa
100%
Low Drug Dose
55%
Drug Megadose
44%
Thrombocyte Activation
11%
Coagulation System
11%
Veterinary Science and Veterinary Medicine
Heparin
100%
Platelet
100%
Unstable Angina
100%
Aspirin
22%
Myocardial Infarction
22%
Thrombus
11%
Agricultural and Biological Sciences
Heparin
100%
Aspirin
22%
Placebo
11%
Platelet Activation
11%
Infarction
11%